Welcome to our dedicated page for Nano Labs SEC filings (Ticker: NA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Nano Labs Ltd filings document its foreign private issuer current reports on Form 6-K, including press releases incorporated by reference into registration statements. These records cover financial results, cryptocurrency holdings and fair-value changes, product announcements for iPollo and OpenClaw, and strategic initiatives tied to Web 3.0 infrastructure.
The filings also record capital and governance matters, including share repurchase activity, annual general meeting proposals, amendments to the memorandum and articles of association, Class B ordinary share voting rights and the appointment of an independent registered public accounting firm.
On 25 June 2025, Nano Labs Ltd (Nasdaq: NA) filed a Form 6-K providing additional detail on its previously announced private placement of convertible promissory notes that could raise up to US$500 million (payable in cash or cryptocurrency) over the next 360 days. Subscriptions may close in multiple tranches.
Initial closing: the company received 600 Bitcoins (≈ US$63.6 million) and issued two unsecured, 360-day notes. These notes are convertible into Class A shares at US$20 per share, a price subject to equitable adjustment if Nano Labs later issues more favorable financing terms.
- No pre-payment allowed; any outstanding principal at maturity must be repaid in Bitcoin.
- Immediate Bitcoin repayment is triggered by a defined change-of-control event.
- The notes carry no collateral, making them senior only by contract.
The company currently holds 1,000 Bitcoins, including the 600 BTC received in this first tranche. Management warns there is no guarantee that investors will subscribe for the full US$500 million before the 360-day window closes.
The filing incorporates the transaction into Nano Labs’ effective Form F-3 shelf and includes customary forward-looking-statement disclaimers regarding market, regulatory and execution risks.
Nano Labs Ltd (Nasdaq: NA) has filed Prospectus Supplement No. 1 to its May 2, 2025 F-1 prospectus, covering the potential resale of 652,174 Class A ordinary shares that may be issued upon exercise of outstanding warrants. The warrants were issued in an April 11, 2024 private placement under a Securities Purchase Agreement. The selling shareholders—not the company—may dispose of the shares at market or negotiated prices, bearing any brokerage commissions. Nano Labs will only receive proceeds if the warrants are exercised for cash; there is no assurance of exercise, and the decision will depend on the market price of the shares (June 20, 2025 closing price: US$12.17).
The supplement incorporates the company’s Form 6-K dated June 24, 2025. Exhibits to the 6-K include (i) a press release and (ii) supplemental risk factors, both now part of the F-3 registration statement first filed August 14, 2023.
Press Release Highlight (Exhibit 99.1): Nano Labs intends to apply—together with partners—for licenses to issue Hong Kong-dollar and offshore RMB stablecoins following passage of the Hong Kong Stablecoins Bill. The company also plans to build a stablecoin technical framework on Bitcoin and BNB chains to support Web 3.0 ecosystem growth. The Hong Kong Stablecoins Ordinance becomes effective August 1, 2025.
Investors should review the Prospectus’ existing Risk Factors (page 12) and the newly furnished supplemental risks. No regulatory authority has approved the securities, and investment in Nano Labs remains high-risk.